Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Tucidinostat in Combination With Fulvestrant in Patients With Hormone-receptor Positive Advanced Breast Cancer

NCT04999540 is registered in ClinicalTrials.gov with Guangdong Women and Children Hospital as lead sponsor.

NCT NCT04999540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04999540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Tucidinostat in Combination With Fulvestrant in Patients With Hormone-receptor Positive Advanced Breast Cancer
Lead sponsor
Guangdong Women and Children Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
November 1, 2021
Completion date
December 30, 2024
Enrollment
73 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer